Jamie Blood, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 307 S. 8th St., St. Maries, ID 83861 Phone: 208-245-2548 |
News Archive
Osiris Therapeutics, Inc. today announced that it is resuming enrollment in its clinical trial evaluating Prochymal for patients with treatment-resistant Crohn's disease. The findings of an interim analysis showed that for the primary endpoint of disease remission, Prochymal is approaching statistical significance in the intent to treat (ITT) population, and has reached significance in the per protocol population.
The U.S. Department of Health and Human Services (HHS) is honoring Children's Hospital Los Angeles for its commitment to saving lives through organ and tissue donation. The hospital will receive the Silver Medal of Honor today for excellence in organ donation at the 7th National Learning Congress for the Donation and Transplantation Community of Practice in Grapevine, Tex.
A new formulation developed by University of South Australia scientists to treat antimicrobial-resistant bacterial infections in diabetic foot ulcers could also be used to kill the COVID-19 virus circulating in air conditioning systems.
Vantia Therapeutics today announces that its novel oral small molecule drug for the treatment of dysmenorrhoea (painful menstruation) has entered Phase II proof-of-concept trials. In addition, Vantia announces results of the successful Phase I trial of VA111913, which showed the product candidate to be safe and well tolerated.
› Verified 5 days ago